Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease-Reference-Cited by-同舟云学术

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

Published:2010-07-21 Issue:6 Volume:105 Page:821-832
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Sattler Katherine J. E.,Elbasan Şehriban,Keul Petra,Elter-Schulz Miriam,Bode Constantin,Gräler Markus H.,Bröcker-Preuss Martina,Budde Thomas,Erbel Raimund,Heusch Gerd,Levkau Bodo

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-010-0112-5.pdf

Reference32 articles.

1. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, Okajima F (2000) Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352:809–815

2. von Eckardstein A, Hersberger M, Rohrer L (2005) Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 8:147–152

3. Zhang B, Tomura H, Kuwabara A, Kimura T, Miura S, Noda K, Okajima F, Saku K (2005) Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis 178:199–205

4. Nofer JR, van der Giet M, Tolle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B, Schafers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B (2004) HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569–581

5. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B (2006) High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114:1403–1409

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untangling the role of RhoA in the heart: protective effect and mechanism;Cell Death & Disease;2024-08-09

2. Syndecan-1 as a predictor of vulnerable atherosclerotic plaques;Frontiers in Cell and Developmental Biology;2024-08-08

3. Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel;Basic Research in Cardiology;2024-08-07

4. Ying and Yang of Ceramide in the Vascular Endothelium;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-08

5. Sphingosine‐1‐phosphate signalling in the heart: exploring emerging perspectives in cardiopathology;FEBS Letters;2024-07-04